JPY 4437.0
(2.05%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 78.97 Billion JPY | 8.63% |
2022 | 72.7 Billion JPY | 3.76% |
2021 | 70.06 Billion JPY | 1.29% |
2020 | 69.17 Billion JPY | -21.04% |
2019 | 87.6 Billion JPY | -1.21% |
2018 | 88.68 Billion JPY | -3.8% |
2017 | 92.18 Billion JPY | -0.63% |
2016 | 92.77 Billion JPY | -10.4% |
2015 | 103.53 Billion JPY | 3.87% |
2014 | 99.68 Billion JPY | 4.75% |
2013 | 95.16 Billion JPY | 4.45% |
2012 | 91.11 Billion JPY | 0.11% |
2011 | 91 Billion JPY | 1.7% |
2010 | 89.48 Billion JPY | 2.65% |
2009 | 87.17 Billion JPY | 2.84% |
2008 | 84.77 Billion JPY | 2.18% |
2007 | 82.96 Billion JPY | 7.9% |
2006 | 76.88 Billion JPY | 5.58% |
2005 | 72.82 Billion JPY | 23.81% |
2004 | 58.82 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 23.6 Billion JPY | 13.45% |
2024 Q1 | 20.8 Billion JPY | 2.13% |
2023 Q1 | 18.71 Billion JPY | -6.03% |
2023 Q2 | 19.92 Billion JPY | 6.47% |
2023 Q4 | 20.37 Billion JPY | 2.09% |
2023 FY | 78.97 Billion JPY | 8.63% |
2023 Q3 | 19.95 Billion JPY | 0.12% |
2022 Q1 | 14.74 Billion JPY | -19.37% |
2022 FY | 72.7 Billion JPY | 3.76% |
2022 Q2 | 19.71 Billion JPY | 33.71% |
2022 Q4 | 19.91 Billion JPY | 8.74% |
2022 Q3 | 18.31 Billion JPY | -7.1% |
2021 Q4 | 18.28 Billion JPY | 11.87% |
2021 Q1 | 16.59 Billion JPY | -10.27% |
2021 Q2 | 18.83 Billion JPY | 13.45% |
2021 FY | 70.06 Billion JPY | 1.29% |
2021 Q3 | 16.34 Billion JPY | -13.19% |
2020 Q3 | 17.32 Billion JPY | -4.49% |
2020 FY | 69.17 Billion JPY | -21.04% |
2020 Q1 | 15.21 Billion JPY | -34.1% |
2020 Q2 | 18.13 Billion JPY | 19.26% |
2020 Q4 | 18.49 Billion JPY | 6.78% |
2019 Q3 | 24.01 Billion JPY | 8.29% |
2019 FY | 87.6 Billion JPY | -1.21% |
2019 Q1 | 18.33 Billion JPY | -24.5% |
2019 Q2 | 22.17 Billion JPY | 20.97% |
2019 Q4 | 23.08 Billion JPY | -3.89% |
2018 Q3 | 21.14 Billion JPY | -9.46% |
2018 FY | 88.68 Billion JPY | -3.8% |
2018 Q1 | 19.89 Billion JPY | -13.09% |
2018 Q4 | 24.28 Billion JPY | 14.84% |
2018 Q2 | 23.35 Billion JPY | 17.37% |
2017 Q2 | 23.8 Billion JPY | 7.81% |
2017 Q1 | 22.07 Billion JPY | 1.18% |
2017 FY | 92.18 Billion JPY | -0.63% |
2017 Q4 | 22.89 Billion JPY | -2.18% |
2017 Q3 | 23.4 Billion JPY | -1.66% |
2016 Q1 | 24.61 Billion JPY | 3.94% |
2016 Q4 | 21.81 Billion JPY | -3.87% |
2016 FY | 92.77 Billion JPY | -10.4% |
2016 Q3 | 22.69 Billion JPY | -3.99% |
2016 Q2 | 23.64 Billion JPY | -3.96% |
2015 Q2 | 27.99 Billion JPY | 11.22% |
2015 Q4 | 23.68 Billion JPY | -11.28% |
2015 Q3 | 26.69 Billion JPY | -4.64% |
2015 FY | 103.53 Billion JPY | 3.87% |
2015 Q1 | 25.16 Billion JPY | -2.05% |
2014 FY | 99.68 Billion JPY | 4.75% |
2014 Q4 | 25.69 Billion JPY | 3.46% |
2014 Q3 | 24.83 Billion JPY | -1.94% |
2014 Q2 | 25.32 Billion JPY | 6.3% |
2014 Q1 | 23.82 Billion JPY | 12.66% |
2013 Q3 | 24.65 Billion JPY | -5.69% |
2013 Q4 | 21.14 Billion JPY | -14.22% |
2013 FY | 95.16 Billion JPY | 4.45% |
2013 Q1 | 23.22 Billion JPY | 5.02% |
2013 Q2 | 26.14 Billion JPY | 12.56% |
2012 Q3 | 23.08 Billion JPY | -2.95% |
2012 Q2 | 23.78 Billion JPY | 7.42% |
2012 FY | 91.11 Billion JPY | 0.11% |
2012 Q4 | 22.11 Billion JPY | -4.19% |
2012 Q1 | 22.13 Billion JPY | 1.44% |
2011 Q2 | 24.01 Billion JPY | 8.64% |
2011 Q3 | 23.07 Billion JPY | -3.91% |
2011 Q4 | 21.82 Billion JPY | -5.41% |
2011 FY | 91 Billion JPY | 1.7% |
2011 Q1 | 22.1 Billion JPY | 0.13% |
2010 Q2 | 25.23 Billion JPY | 17.77% |
2010 Q1 | 21.42 Billion JPY | 5.16% |
2010 Q4 | 22.07 Billion JPY | 6.39% |
2010 FY | 89.48 Billion JPY | 2.65% |
2010 Q3 | 20.74 Billion JPY | -17.79% |
2009 Q2 | 23.51 Billion JPY | 14.58% |
2009 Q1 | 20.52 Billion JPY | 0.0% |
2009 FY | 87.17 Billion JPY | 2.84% |
2009 Q4 | 20.37 Billion JPY | -10.45% |
2009 Q3 | 22.75 Billion JPY | -3.24% |
2008 FY | 84.77 Billion JPY | 2.18% |
2007 FY | 82.96 Billion JPY | 7.9% |
2006 FY | 76.88 Billion JPY | 5.58% |
2005 FY | 72.82 Billion JPY | 23.81% |
2004 FY | 58.82 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -61.985% |
Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 96.386% |
Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 57.99% |
Shionogi & Co., Ltd. | 369.08 Billion JPY | 78.604% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -2130.285% |
Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 18.601% |
Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -106.611% |
Eisai Co., Ltd. | 586.41 Billion JPY | 86.533% |
Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -1216.622% |
Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | -51.663% |
Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -484.235% |
Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -920.561% |
Tsumura & Co. | 68.81 Billion JPY | -14.755% |
Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -111.486% |
Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -218.534% |
Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 2.964% |
Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -378.177% |
Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -57.371% |
KYORIN Holdings, Inc. | 51.4 Billion JPY | -53.64% |
Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -7218.906% |
Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -702.632% |
SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1690.314% |
MedRx Co., Ltd | 26 Million JPY | -303634.615% |
Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -883.974% |
Solasia Pharma K.K. | 337 Million JPY | -23333.531% |
Modalis Therapeutics Corporation | -731 Thousand JPY | 10803246.375% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -157.528% |
Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | -45.384% |
Cyfuse Biomedical K.K. | 37.74 Million JPY | -209127.957% |
Toho Holdings Co., Ltd. | 112.98 Billion JPY | 30.105% |
Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -1089.394% |